ChiCTR2600121283 版本V1.0 版本创建时间2026/03/27 16:11:34 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600121283 

最近更新日期:

Date of Last Refreshed on:

2026-03-27 16:11:23 

注册时间:

Date of Registration:

2026-03-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于可视组合式导管的“全程无体位变动”气道管理策略在胸科手术中的构建与应用评价

Public title:

Construction and application evaluation of a "no positional change throughout" airway management strategy based on visually integrated catheters in thoracic surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于可视组合式导管的“全程无体位变动”气道管理策略在胸科手术中的构建与应用评价

Scientific title:

Construction and application evaluation of a "no positional change throughout" airway management strategy based on visually integrated catheters in thoracic surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

文也新 

研究负责人:

文也新 

Applicant:

Yexin Wen 

Study leader:

Yexin Wen 

申请注册联系人电话:

Applicant telephone:

+86 158 0205 2288

研究负责人电话:

Study leader's
telephone:

+86 158 0205 2288

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yexin.wen@outlook.com

研究负责人电子邮件:

Study leader's E-mail:

yexin.wen@outlook.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省汕头市外马路114号

研究负责人通讯地址:

广东省汕头市外马路114号

Applicant address:

No. 114 Waima Road, Shantou City, Guangdong Province

Study leader's address:

No. 114 Waima Road, Shantou City, Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

汕头市中心医院

Applicant's institution:

Shantou Central Hospital

研究负责人所在单位:

汕头市中心医院

Affiliation of the Leader:

Shantou Central Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

{2026}科研007号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

汕头市中心医院伦理委员会

Name of the ethic committee:

Shantou Central Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2026-02-11 00:00:00

伦理委员会联系人:

杨春枝

Contact Name of the ethic committee:

Chunzhi Yang

伦理委员会联系地址:

广东省汕头市外马路114号

Contact Address of the ethic committee:

No. 114 Waima Road, Shantou City, Guangdong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 754 8965 3326

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

汕头市中心医院

Primary sponsor:

Shantou Central Hospital

研究实施负责(组长)单位地址:

广东省汕头市外马路114号

Primary sponsor's address:

No. 114 Waima Road, Shantou City, Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

汕头

Country:

China

Province:

Guangdong

City:

Shantou

单位(医院):

汕头市中心医院

具体地址:

广东省汕头市外马路114号

Institution
hospital:

Shantou Central Hospital

Address:

No. 114 Waima Road, Shantou City, Guangdong Province

经费或物资来源:

自筹

Source(s) of funding:

Self-financing

研究疾病:

无  

Target disease:

None

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究拟将可视组合式支气管导管(VCBT)与"侧卧位直接插管"策略结合,构建"全程无体位变动"的气道管理新模式。研究成果将有望:降低导管移位率,减少术中纤维支气管镜调整次数;缩短麻醉准备时间,提高手术室周转效率;降低气道损伤风险,改善患者围术期安全与舒适度;建立标准化操作流程,为各医院推广提供技术规范。  

Objectives of Study:

This study aims to combine the Visual Combined Bronchial Tube (VCBT) with the "lateral decubitus direct intubation" strategy to construct a new airway management model with "no positional change throughout the procedure." The research findings are expected to: reduce tube displacement rate and decrease the number of intraoperative fiberoptic bronchoscopy adjustments; shorten anesthesia preparation time and improve operating room turnover efficiency; reduce the risk of airway injury and improve patient perioperative safety and comfort; and establish standardized operating procedures to provide technical guidelines for hospital implementation.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 美国麻醉医师协会(ASA)分级I~III级; 2. 年龄18~75岁; 3. 患者意识清醒,表述清楚,能配合操作,理解调查内容; 4. 术前无严重听力、视觉和运动障碍; 5. 自愿参与研究并已签署知情同意书。

Inclusion criteria

1. American Society of Anesthesiologists (ASA) classification I–III; 2. Age 18–75 years; 3. Patient is conscious, able to express clearly, cooperate with procedures, and understand the survey content; 4. No severe hearing, vision, or motor impairments before surgery; 5. Voluntarily participates in the study and has signed the informed consent form.

排除标准:

1. 困难气道病史; 2. BMI>35 kg/m^2; 3. 麻醉药物过敏史; 4. 长期接受镇痛、镇静药物治疗史和吸毒史者; 5. 精神病病史或不合作者; 6. 心功能不全或心脏传导阻滞; 7. 肾功能衰竭; 8. 活动性肝病患者; 9. 严重的视力或听力障碍者; 10. 文盲或在语言上无法与医师沟通的患者; 11. 孕妇、残障人士。

Exclusion criteria:

1. History of difficult airway; 2. BMI > 35 kg/m^2; 3. History of allergic reaction to anesthetic drugs; 4. History of long-term use of analgesics or sedatives, or history of drug abuse; 5. History of psychiatric disorders or uncooperative patients; 6. Heart failure or cardiac conduction block; 7. Renal failure; 8. Patients with active liver disease; 9. Severe visual or hearing impairment; 10. Illiterate patients or those unable to communicate with the physician verbally; 11. Pregnant women and individuals with disabilities.

研究实施时间:

Study execute time:

From 2026-03-01 00:00:00 To 2027-02-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-04-01 00:00:00 To 2026-07-01 00:00:00

干预措施:

Interventions:

组别:

侧卧位VCBT插管

样本量:

56

Group:

Lateral decubitus position VCBT intubation

Sample size:

干预措施:

侧卧位下行可视组合式支气管导管插管

干预措施代码:

Intervention:

Lateral decubitus position visual combined bronchial tube intubation

Intervention code:

组别:

仰卧位VDLT插管

样本量:

56

Group:

Supine VDLT intubation

Sample size:

干预措施:

仰卧位下行可视双腔支气管导管插管

干预措施代码:

Intervention:

Supine position, visual double-lumen endotracheal tube intubation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

汕头市 

Country:

China

Province:

Guangdong

City:

Shantou

单位(医院):

汕头市中心医院 

单位级别:

三甲 

Institution
hospital:

Shantou Central Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

导管移位率

指标类型:

主要指标

Outcome:

catheter displacement rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

插管时间(从喉镜置入至导管固定完成的时间)

指标类型:

次要指标

Outcome:

Intubation time (the time from insertion of the laryngoscope to completion of catheter fixation)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

首次插管成功率

指标类型:

主要指标

Outcome:

First intubation success rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中低氧血症发生率

指标类型:

主要指标

Outcome:

Intraoperative hypoxemia incidence

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

咽喉部损伤发生率

指标类型:

主要指标

Outcome:

Incidence of throat injury

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血流动力学变化

指标类型:

主要指标

Outcome:

Hemodynamic changes

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用数字随机表法,将入选患者随机分为仰卧位组和侧卧位组

Randomization Procedure (please state who generates the random number sequence and by what method):

Using the digital random table method, the selected patients were randomly divided into the supine position group and the lateral position gro

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

对参试者数据收集、统计分析者实施盲法

Blinding:

Implement blinding for participants, data collectors, and statisticians

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-03-27 16:11:23